Real-world evidence supporting orphan drugs approvals for rare neuromuscular disorders in the European Union and the United States: Review of public assessment reports (2015–2025)

Current Opinion in Pharmacology · Published 2025-11-18 · DOI 10.1016/j.coph.2025.102586

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.coph.2025.102586

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2025

Related articles